Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Discovery Ltd.

Latest From Drug Discovery Ltd.

Indian plants rate high on cost efficiency, says study

India rates highest in terms of cost-efficiency attractiveness among six prominent manufacturing locations including China, Singapore and eastern Europe, according to a study by Ernst & Young.


BioIT Alliance makes board appointment

The BioIT Alliance (US) has appointed Dr Frank Brown, senior vice-president and chief science officer of Accelrys, to its board of directors. Formed in 2006, the BioIT Alliance is a group of organisations working together to accelerate drug discovery in the area of personalised medicines.


Dr Jan Hoflack joins Oncodesign

Dr Jan Hoflack has joined Oncodesign Biotechnology (France), a company focused on the identification of cancer therapies, as vice-president of drug discovery. Dr Hoflack was previously vice-president medicinal chemistry and biosciences at Johnson & Johnson Pharmaceutical R&D in Belgium.

Cancer France

NeuroSearch and Janssen sign development deal

NeuroSearch and Janssen Pharmaceutica have agreed to develop and commercialise jointly new treatments for various central nervous system diseases, based on the companies' joint expertise in neuroscience.

Neurology Companies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products